Metformin News and Research

RSS
Metformin is the active ingredient in a drug used to treat diabetes mellitus (a condition in which the body cannot control the level of sugar in the blood). It is also being studied in the treatment of cancer. It decreases the amount of glucose (a type of sugar) released into the bloodstream from the liver and increases the body’s use of the glucose. Metformin is a type of antidiabetic agent.
Cleveland Clinic receives $3.7 million grant from AHA for atrial fibrillation research

Cleveland Clinic receives $3.7 million grant from AHA for atrial fibrillation research

Girls with type 2 diabetes have high frequency of menstrual irregularities

Girls with type 2 diabetes have high frequency of menstrual irregularities

Hacking 'drug trafficking' system could increase effectiveness of diabetes treatment

Hacking 'drug trafficking' system could increase effectiveness of diabetes treatment

One class of diabetes drug not associated with reduced risk of death

One class of diabetes drug not associated with reduced risk of death

Screening strategies could reduce multiple myeloma prevalence, mortality

Screening strategies could reduce multiple myeloma prevalence, mortality

Bariatric surgery linked to positive outcomes in very obese adolescents with type 2 diabetes

Bariatric surgery linked to positive outcomes in very obese adolescents with type 2 diabetes

Diabetes medication reduces chance of late miscarriage, premature birth among women with PCOS

Diabetes medication reduces chance of late miscarriage, premature birth among women with PCOS

Newer treatment for type 2 diabetes reduces liver fat in patients with NAFLD

Newer treatment for type 2 diabetes reduces liver fat in patients with NAFLD

Diabetes drug use during pregnancy may increase risk of obesity or overweight in children

Diabetes drug use during pregnancy may increase risk of obesity or overweight in children

Scientists find new way to kill liver cancer cells

Scientists find new way to kill liver cancer cells

Study reveals lack of access to essential medicines in India

Study reveals lack of access to essential medicines in India

FDA-approved drug to treat high blood pressure increases life span in worms

FDA-approved drug to treat high blood pressure increases life span in worms

Diabetes patients least likely to follow medical advice regarding medication due to side effects

Diabetes patients least likely to follow medical advice regarding medication due to side effects

Adults as likely to develop type 1 diabetes as children, research finds

Adults as likely to develop type 1 diabetes as children, research finds

Genome-wide molecular tests can guide treatment in recurrent glioblastoma, study shows

Genome-wide molecular tests can guide treatment in recurrent glioblastoma, study shows

Researchers evaluate potential of stem cells, therapeutic agents in neurodegenerative diseases

Researchers evaluate potential of stem cells, therapeutic agents in neurodegenerative diseases

Review finds no increased cancer risk for people taking oral diabetes medication

Review finds no increased cancer risk for people taking oral diabetes medication

Doctors and older patients should work together to dial back diabetes treatment, study suggests

Doctors and older patients should work together to dial back diabetes treatment, study suggests

Abdominal weight found to be key predictor of cancer risk in  postmenopausal women

Abdominal weight found to be key predictor of cancer risk in postmenopausal women

Climbing cost of decades-old drugs threatens to break Medicaid bank

Climbing cost of decades-old drugs threatens to break Medicaid bank

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.